Back to mobile site

Wedbush Starts Cyteir Therapeutics (CYT) at Outperform

July 13, 2021 6:45 AM EDT
Get Alerts CYT Hot Sheet
Price: $3.02 --0%

Rating Summary:
    5 Buy, 6 Hold, 2 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 10 | Down: 20 | New: 6
Join SI Premium – FREE

Wedbush analyst Robert Driscoll initiates coverage on Cyteir Therapeutics (NASDAQ: CYT) with a Outperform rating and a price target of $40.00.


For an analyst ratings summary and ratings history on Cyteir Therapeutics click here. For more ratings news on Cyteir Therapeutics click here.


Shares of Cyteir Therapeutics closed at $19.65 yesterday.


You May Also Be Interested In





Related Categories

New Coverage